1-6 of 6
Amber L. Gordon
Close
Sort by
Journal Articles

Mir-155 Expression Is Associated with Chemoimmunotherapy Outcome and Is Modulated By Bruton’s Tyrosine Kinase Inhibition with Ibrutinib

Daphne Guinn, Amy S. Ruppert, MAS, Kami J. Maddocks, MD, Samantha Jaglowski, MD MPH, Amber L. Gordon, Thomas S. Lin, MD PhD, Richard A. Larson, Guido Marcucci, MD, Erin K Hertlein, PhD, Jennifer A. Woyach, MD, Amy J. Johnson, PhD, John C. Byrd, MD
Journal: Blood
Blood (2014) 124 (21): 3297.
https://doi.org/10.1182/blood.V124.21.3297.3297
Published: 2014
Journal Articles

Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765

Sarah E. M. Herman, Amber L. Gordon, Erin Hertlein, Asha Ramanunni, Xiaoli Zhang, Samantha Jaglowski, Joseph Flynn, Jeffrey Jones, Kristie A. Blum, Joseph J. Buggy, Ahmed Hamdy, Amy J. Johnson, John C. Byrd
Journal: Blood
Blood (2011) 117 (23): 6287–6296.
https://doi.org/10.1182/blood-2011-01-328484
Published: 2011
Journal Articles

The role of phosphatidylinositol 3-kinase-δ in the immunomodulatory effects of lenalidomide in chronic lymphocytic leukemia

Brief Report
Sarah E. M. Herman, Rosa Lapalombella, Amber L. Gordon, Asha Ramanunni, Kristie A. Blum, Jeffrey Jones, Xiaoli Zhang, Brian J. Lannutti, Kamal D. Puri, Natarajan Muthusamy, John C. Byrd, Amy J. Johnson
Journal: Blood
Blood (2011) 117 (16): 4323–4327.
https://doi.org/10.1182/blood-2010-11-315705
Published: 2011
Journal Articles

Lenalidomide-Dependent Activation of the Phosphatidylinositol 3-kinase-δ Pathway Is Antagonized by CAL-101 In Chronic Lymphocytic Leukemia

Sarah E.M. Herman, Rosa Lapalombella, Jeffrey A. Jones, MD, MPH, Leslie Andritsos, MD, Amber L. Gordon, Asha Ramanunni, Brian Lannutti, PhD, Natarajan Muthusamy, DVM, PhD, John C. Byrd, MD, Amy J. Johnson, PhD
Journal: Blood
Blood (2010) 116 (21): 1821.
https://doi.org/10.1182/blood.V116.21.1821.1821
Published: 2010
Journal Articles

The Kinase Inhibitor, PCI-32765, Demonstrates Activity In Chronic Lymphocytic Leukemia Cells Independent of Microenvironmental Survival Signals

Sarah E.M. Herman, Amber L. Gordon, Emilia Mahoney, MD, PhD, Samantha M. Jaglowski, MD, Kristie A. Blum, MD, Joseph Buggy, PhD, Ahmed Hamdy, MD, John C. Byrd, MD, Amy J. Johnson, PhD
Journal: Blood
Blood (2010) 116 (21): 1385.
https://doi.org/10.1182/blood.V116.21.1385.1385
Published: 2010
Journal Articles

Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals

Sarah E. M. Herman, Amber L. Gordon, Amy J. Wagner, Nyla A. Heerema, Weiqiang Zhao, Joseph M. Flynn, Jeffrey Jones, Leslie Andritsos, Kamal D. Puri, Brian J. Lannutti, Neill A. Giese, Xiaoli Zhang, Lai Wei, John C. Byrd, Amy J. Johnson
Journal: Blood
Blood (2010) 116 (12): 2078–2088.
https://doi.org/10.1182/blood-2010-02-271171
Published: 2010